Antibiotic resistance will continue to rise in the human population unless alternative therapies are developed. AmpliPhi is harnessing the power of phage therapeutics to provide additional treatment options to better control infections and create more targeted treatments that have fewer side effects.

“The world is headed for a post-antibiotic era, in which common infections and minor injuries which have been treatable for decades can once again kill”

– Dr. Keiji Fukuda, WHO’s Assistant Director-General for Health Security, 2014